Schizophrenia / Schizoaffective Disorder
12
3
4
4
Key Insights
Highlights
Success Rate
80% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
8.3%
1 terminated out of 12 trials
80.0%
-6.6% vs benchmark
8%
1 trials in Phase 3/4
75%
3 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 4 completed trials
Clinical Trials (12)
Healing Stigma Through Stories
FEEL-GOOD: A Multicenter Trial of a Mindfulness-Based Group Therapy in Young Adults With Early Psychosis
The Effect of Structured Medical Nutrition Therapy on Systemic Inflammation Index in Patients With Schizophrenia Receiving Antipsychotic Therapy
A Cognitive Mobile Intervention for Motivation in Psychotic Disorders
Topiramate and Schizophrenia: Effects on Weight and Psychopathology
NST-SPARK Open-Label Phase 1 STTR (IGNITE)
Brain Imaging of Cognition Inn Schizophrenia and Depression
Open-label Trial Characterizing the PK of 3 SC Olanzapine Extended-release Formulations in Participants With Schizophrenia/Schizoaffective Disorder
A Study to Assess the Effects of RO6889450 (Ralmitaront) in Participants With Schizophrenia or Schizoaffective Disorder and Negative Symptoms
A Trial of the Efficacy and the Safety of RO6889450 (Ralmitaront) vs Placebo in Patients With an Acute Exacerbation of Schizophrenia or Schizoaffective Disorder
Computerized Cognitive-Behavioral Therapy for Auditory Hallucinations
Clozapine-Augmentation With Ziprasidone or Risperidone, a Randomized, Prospective Trial